Anti-inflammatory and antioxidant feeding and supplementation may serve as adjuvants in women with fibromyalgia

Martín, Ismael San Mauro; Oliva, Sara López; Yurrita, Luis Collado; Rojo, Sara Sanz; Vilar, Elena Garicano

doi:10.1016/j.jnim.2018.11.002

Cited by 5 publications

(3 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Various studies have evaluated the efficacy of turmeric and curcumin in treating neurological disorders. For example, a study showed that administration of a 500 mg turmeric-based supplement reduced the severity of symptoms in women with fibromyalgia . Another study showed that 2 or 4 g of curcumin C3 complex in Alzheimer’s disease for 24 weeks was well tolerated .…”

Section: Clinical Trials Of Turmeric and Curcuminmentioning

confidence: 99%

“…For example, a study showed that administration of a 500 mg turmeric-based supplement reduced the severity of symptoms in women with fibromyalgia. 618 Another study showed that 2 or 4 g of curcumin C3 complex in Alzheimer's disease for 24 weeks was well tolerated. 619 Moreover, in a randomized double-blind clinical trial, curcumin (600 mg/day) reduced the levels of advanced oxidation protein products and increased amyotrophic lateral sclerosis (ALS) functional rating scale (ALS-FRS-r) and ferric reducing ability (FRAP) stable scores in patients with ALS (a progressive neurodegenerative disorder).…”

Section: Turmeric and Curcumin In Inheritedmentioning

confidence: 99%

See 1 more Smart Citation

Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials

Kunnumakkara

Hegde

Dey

et al. 2023

ACS Pharmacol. Transl. Sci.

View full text Add to dashboard Cite

Turmeric (Curcuma longa) has been used for thousands of years for the prevention and treatment of various chronic diseases. Curcumin is just one of >200 ingredients in turmeric. Almost 7000 scientific papers on turmeric and almost 20,000 on curcumin have been published in PubMed. Scientific reports based on cell culture or animal studies are often not reproducible in humans. Therefore, human clinical trials are the best indicators for the prevention and treatment of a disease using a given agent/drug. Herein, we conducted an extensive literature survey on PubMed and Scopus following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The keywords "turmeric and clinical trials" and "curcumin and clinical trials" were considered for data mining. A total of 148 references were found to be relevant for the key term "turmeric and clinical trials", of which 70 were common in both PubMed and Scopus, 44 were unique to PubMed, and 34 were unique to Scopus. Similarly, for the search term "curcumin and clinical trials", 440 references were found to be relevant, of which 70 were unique to PubMed, 110 were unique to Scopus, and 260 were common to both databases. These studies show that the golden spice has enormous health and medicinal benefits for humans. This Review will extract and summarize the lessons learned about turmeric and curcumin in the prevention and treatment of chronic diseases based on clinical trials.

show abstract

Section: Clinical Trials Of Turmeric and Curcuminmentioning

confidence: 99%

Section: Turmeric and Curcumin In Inheritedmentioning

confidence: 99%

Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials

Kunnumakkara

Hegde

Dey

et al. 2023

ACS Pharmacol. Transl. Sci.

View full text Add to dashboard Cite

show abstract

“…Observou-se diminuição na intensidade dos sintomas como fadiga e melhora do sono, com exceção de náuseas e vômitos. Contudo, o tamanho da amostra também é pequeno, não sendo suficiente para representar a realidade (SILVA et al, 2021;MARTIN et al, 2019). 18 ensaios de controle randomizados (RCTs) e 04 pesquisas de coorte.…”

Section: Pesquisas E Debates Sobreunclassified

Consumo De Fodmap E Os Sintomas Em Fibromiálgicos: Uma Revisão Integrativa

Carvalho,

Silva,

Melo

et al. 2023

Pesquisas E Debates Sobre a Saúde Coletiva: Um Intercâmbio Entre Brasil E Portugal

View full text Add to dashboard Cite

A saúde coletiva é um campo da saúde pública que se concentra na promoção da saúde e na prevenção de doenças em populações. No Brasil e em Portugal, a saúde coletiva é um tema de grande importância, dada a relevância dos problemas de saúde pública nos dois países.O Brasil e Portugal compartilham alguns desafios comuns na área da saúde coletiva, como: desigualdades sociais, envelhecimento populacional e doenças crônicas não transmissíveis. Apesar dos desafios, o Brasil e Portugal também têm feito progressos na área da saúde coletiva, por meio da ampliação do acesso à saúde no Brasil, com o Sistema Único de Saúde (SUS) e em Portugal, com o Serviço Nacional de Saúde (SNS).O Brasil e Portugal têm uma longa história de cooperação na área da saúde. Em 2023, os dois países assinaram um acordo de cooperação em saúde coletiva. O acordo visa promover a cooperação entre os dois países em áreas como: pesquisa e desenvolvimento, formação profissional e troca de experiências. A cooperação entre o Brasil e Portugal na área da saúde coletiva tem o potencial de contribuir para a melhoria da saúde das populações dos dois países.Em nossos livros selecionamos um dos capítulos para premiação como forma de incentivo para os autores, e entre os excelentes trabalhos selecionados para compor este livro, os capítulos que receberam menção honrosa foram listados abaixo.

show abstract